Clinical development programme of peginterferon alfa-2a (40KD) for the treatment of chronic hepatitis - [Basel : Roche], 2004 - 20 s. [1, currently available 1]
Chapters, articles
This site uses cookies to make them easier to browse. Learn more about
how we use cookies.